A single-center prospective observational study of stereotactic radiotherapy for brain metastases

A single-center prospective observational study of stereotactic radiotherapy for brain metastases - A single-center prospective observational study of stereotactic radiotherapy for brain metastases

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000047058

Enrollment

Registered

2022-03-02

Start date

2022-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain metastases

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients receive stereotactic radiotherapy for brain metastases 2) Age <= 20 years old 3) Written informed consent

Exclusion criteria

Exclusion criteria: 1) Unable to receive stereotactic radiotherapy 2) Unable to obtain written informed consent 3) Inappropriate patients for this study judged by physicians

Design outcomes

Primary

Measure	Time frame
Proportion of radiation necrosis	—

Secondary

Measure	Time frame
Overall survival, local control period	—

Countries

Japan

Contacts

Public ContactShigeo TAKAHASHI

Kagawa University Hospital Department of Radiation Oncology

takahashi.shigeo@kagawa-u.ac.jp087-898-5111

Outcome results